Venous Access Devices Market Analysis

Device Type (Ablation Device, Surgical Products, Catheter, Venous Closure System)

In terms of device type, the catheter segment is set to hold the largest market share of 40% during the forecast period. With a preference for central catheters, a large proportion of total demand is generated. Direct administration of nutrition and medication directly to the blood vessels is more efficient with centrally placed catheters. To allow patients to remain active and receive intravenous medicinal products at home, central venous catheters are less likely to break off from the vein. In addition, it is capable of providing more blood volume to patients who are severely injured.

End Use (Hospital, Retail Pharmacies, Mail Order Pharmacies, E-commerce)

Based on application, the hospital segment is set to hold the largest market share of 40% by the end of 2037. The presence of qualified and trained staff at dialysis centers and hospitals allows for the best possible care, as well as improved access to blood vessels. A number of reasons, including a growing emphasis by companies on the development of their own cardiovascular access facilities, are anticipated to contribute to this category.

Our in-depth analysis of the global market includes the following segments:

Device Type	Ablation Device Surgical Products Catheter Venous Closure System
Treatment Type	Endovenous Ablation Powder Sclerotherapy Surgical Ligation Stripping
End Use	Hospital Retail Pharmacies Mail Order Pharmacies E-commerce

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of venous access devices is assessed at USD 8.89 billion.

The venous access devices market size was valued at USD 8.58 billion in 2024 and is expected to reach USD 15.21 billion by 2037, expanding at around 4.5% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of chronic disease and growing technological advancement will drive the market growth.

North America industry is likely to account for largest revenue share of 35% by 2037, due to rising substantial incidence of chronic diseases in the region.

The major players in the market are of Baxter International, C R Bard, Reinventing Venous Access, Becton Dickinson and Company, Boston Scientific Corporation, Teleflex Incorporated., and others.

Venous Access Devices Market Analysis